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Chemokines are thought to play a central role in the 
recruitment and activation of leukocytes during in-
flammatory responses. Monocyte chemoattractant 
protein 1 (MCP-1) is a chemokine of the C-C or f3 
family that is chemotactic i11 11itro for monocytes, T 
cells, and basophils. Its excessive production by ke-
ratinocytes has been implicated in psoriasis and other 
skin diseases. To test the in 11i11o role of MCP- 1 in 
inflammatory skin disease, we undertook the gener-
ation of transgenic mice that express murine MCP-1 
in the basal layer of epidennis. Despite production of 
high levels of functional MCP-1 by basal keratino-
cytes, documented i11 11i11o and i11 lliti'O, these 1nice did 
not exhibit spontaneous cutaneous inflammation or 
any other discernible skin pathology. In contrast, 
e licited inflammation in the skin of these mice dif-
fered qualitatively and quantitatively from that ob-
served in non-transgenic controls. Contact hypersen-
sitivity challenge responses in transgenic animals 
C hcm okines are a family of polypeptides that govern th e c.hemotaxis _and activa tion of d_ifferet.1t subsets o f leukocytes dunng tmmune and mflammatory re-sponses [1-3]. In terleukin 8, the first chemokine described, appears to have predominant effects on 
neutropllils and belongs to the a chemokine famny, in which the 
firs t pa ir of cyste ine residues is separated by an intervening amino 
acid (C-X-C) [ 4]. Monocyte chemoattractant protein 1 (MCP- 1) is 
a prototype of the {3 chemokin e family , in which the first pair of 
cysteines are contiguous (C-C) [1,5] . Although both fami lies have 
gained multiple new m embers in recent years, no evidence has 
emerged that has challenged the original concept of chem okines as 
"emergency mo lecules," w hose prin cipal ro le is in the ini tiation 
and maintenance of inflamm atory responses [1] . 
Human MC P-1 was first purified and cloned fi·om a human 
mye lo m onocytic line [6] and mitogen-stimula ted human blood 
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were characterized by an exaggerated lichenoid infil-
tration of monocytes and T cells. Additional pheno-
typic characterization of the normal appearing skin 
in these mice showed that the only spontaneous 
change was a dramatic increase and redistribution of 
CD45 +, 1-A + cells that assumed a dendritic morphol-
ogy i11 situ, including a subset that expressed markers 
characteristic of Langerhans cells. Taken together, 
these data indicate that tissue-specific expression of 
MCP-1 alone is not sufficient to induce an inflamma-
tory response, though its presence can modify in-
flammatory and immune events initiated by exoge-
nous stimuli. The recruitment of dendritic and 
Langerhans cells in the absence of inflammation is 
a previously unknown consequence of cutaneous 
MCP-1 production i11 llillo. KeJI words: epidel'lllis/leuk.o-
cJite migvatio11/T celtslchemokines. J ln11est De1·matol 105: 
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mononuclear ce lls (7]. MCP-1 was found to be homologous to the 
J E gene , a platelet-derived growth factor-inducib le cytokine de-
rived fro m murine fibrob lasts (8]. J E/ M C P-1 has been shown to 
selec tive ly attract and activate monocytes (9] . Studies with human 
MCP-1 have shown that receptor binding of MCP- 1 is associated 
w ith rapid Ca + + flux [1 0, 11] . In addition to its activity on 
monocytes, M C P-1 is strongly chemotactic for human T cells [1 2] 
and can both attract basophils and induce them to re lease histamine 
(1 3]. Although few cells produce MCP-1 constitutively, multiple 
cell typ es have been shown to express the MCP-1 gene upon 
cytokine stimu lation and in inflamm atory diseases [14-1 8] . Identi-
fi ca tion of M C P-1 overexpress ion in the se tting of human inflam-
m atory diseases , including psoriasis ( 48] and rheumatoid arthritis 
(1 9], sa rcoidosis (20], and atherosclerosis (21], has streng then ed the 
n otion that this chemokine is instrumental in the evolution of tissue 
inflamm ation. However, the contribution of this chem okine i 11 11 i 11o 
to cutaneous inflammation has no r been forma lly tested. 
To address rhis question , we have created a series of transgeni c 
mice that constitutively produce murine MCP-1/JE in epidermis 
under the control of the human kera tin 14 (K14) promoter. These 
mice were entire ly normal in appearance, and did not develop 
spontaneous skin disease or othe r evidence of spontaneous cman e-
ous inflammation, despite the fact that MC P- 1 production by basal 
keratinocytes was readily demonstrable . T his did not appear to be 
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F ig ure 1. T r a n sgenic construct u sed to produce K14/MCP-1 mice. 
R estriction sites are indicated by capita l letters (E: EcoRJ , B : Baml-11 ). T he 
4.6- kb segment of DNA isolated after Eco iU digestion and used fo r 
microinjection is illustrated . T hi s construct includes the human K14 pro-
moter/enhancer, a murine MC P-1 eDNA containi ng all codin g sequences 
and a stop codon , and a portion of the hGI-1 gene. T he sm all letters indicate 
the site of anneali ng of sense {a and c) and antisense (b and d) o ligonucle-
otide prim ers used for PCR am pli fication of transgene-encoded mRNA . 
due to desensitization and subsequent n on responsiveness of target 
cells to M CP- 1., because the magn itude of contac t hypersensitivity 
(CHS) responses was increased in these animals. T his enhancement 
of CHS responses was coupled with a redistribution of inflamma-
tory cells from th e deep dermis to the dermal epidermal junction. 
T his lichenoid pattern persisted after even the inflammatory re-
sponse had peaked , sugges ting that infl ammatory leukocytes elic-
ited by C H S responded to a gradien t of MC P-1 em anating from the 
basa l laye r of epidermis. A redistribu tion of dendritic leukocytes 
(including Langerh ans cells) was also observed in MC P-1 trans-
genic mice . 
M ATERIALS AN D METH ODS 
Generation o f DNA C o nstruct T he plasmid pcJE-1 [8] containing a 
578-bp eDNA for mu rine JE {MCP-1) was kindly prov ided by Dr. Barrett 
Rollins (Dana Fa rber Cancer Institu te, Boston , M A). Included within the 3' 
untranslated sequence of this eDNA are two potential polyadenylation 
signals and one copy of an AT- rich instabili ty sequence. To tru ncate these 
3' clements from the transgenic construct, a 534-bp EcoRI-Asel fragm ent 
that terminated within the fi rs t po lyadenylati on signa l was excised from 
pcJE-1, treated with mung bean nuclease to create blunt ends, and ligated 
to Baml-11 linkers. The resul ting Baml-11 fragme nt was inserted into the Bam 
H I site of the K 14/hGH expression vector [221, lcindly provided by Dr. 
Elaine Fuchs (Uni versity of Chicago, C hicago, IL) . T he 4.6- kb EcoRI 
fragmen t of tlus plasmid used fo r micro injection is illustrated in Fig 1. 
Microinjection a nd Ge n e r a tion o f Transgenic Mice Transgen ic 
mice were m ade by pronuclear injection of inbred FVB / N embryos 
(Taconic, Germantown, NY) as described previo usly [23]. T ransgenic 
fo unde rs were identi fied by PCR amplification of tail slci n D N A with 
human growth hormone (hGI-1) specific primers [23] and confirmed by 
Southern blot analysis. 
Rev erse Tra n scriptase-Polymerase Chain Reaction (RT -PCR) 
Analysis Total RNA was isolated by homogenizing mouse ti ssues in 
guanid inium isothiocyanate and cen tri fuging the homogenate through a 
cesium chloride cushion . T he RNA was treated with l~ase-free DNase 
(Boehringer Mannheim, Indianapolis, IN) to eliminate any residual genomic 
DNA. eDNA was synthesized in a volume of 30 !J.I by incubating 2 IJ.g 
ali quots of D N ase- treated RNA with 100 pmoles of random hexamer 
primers and 200 UIU ts of Moloney murine leukemia virus reverse tran-
sc riptase (G!BCO-BR L, Gaithersburg, M D) at 42°C fo r 1 h in the presence 
of dNTPs and R.N ase inhibitor (Boehringer Mannheim). T he eD N A was 
am plified by 35 cycles of PC R {94°C fo r 1 min , 55°C fo r 1 min , 72°C fo r 
2 m in) with pa irs of o ligonucleotide primers specific for mo use MC P-1 , 
hGI-1 , and mouse /3-actin . The primer sequences (5' prim er listed fi rst) and 
the predicted sizes of the am plimers were as fo llows: 1) m ouse M CP-1 (42 1 
bp), 5'-GAAGCCAGCTCTCTCTTCCT-3' and 5'-GTGCTTGAGGTG-
GTTGTGGA-3'; 2) hGI-1 (94 bp), 5'-CTCACCTAGCTGCAATGG- 3' 
and 5'-AAGGCACTGCCCTCTTGAAGC-3'; and 3) m ouse /3-actin (540 
bp), 5'-GTGGGCCGCTCTAGGCACCAA-3 ' and 5'-CTCTTTGATGT-
CACGCACGATTTC-3'. T he annea ling sites within the transgene for the 
MCP-1 and hGI-1 primer pairs arc shown in Fig 1. Products of PC R 
am pli fications were analyzed on 1.5'Yo agarose gels. 
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F ig ure 2. RT-PCR ana lysis ofK14/MCP-1 transgcne expression in 
multiple tissues. A) l~A prepa red from ca r epidermis {M24 line) was 
used as a tc1nplatc fo r eDNA syn thes is usin g randon1 hcxan1 crs as the 
primer. T he eD N A was ampli fied by PC R with primers specif1c fo r mouse 
MCP-1 mi~A (ln11es 1 n11d 4), hG H m R.NA ( l t~ ll cs 2 n11tl 5) , and m ouse 
/3-actin m l~A (ln11cs 3 n11d 6). Ln11 cs 1-3 show PCR. prod ucts of K14 / 
MCP-1 m ice and ln11es 4- 6 show those of nontnmsgenic mice. B) T issue 
specificity of MC P-1 transgcne exp ression in M24 line was analyzed using 
mR.NA prepa red fro m ear epidermis (lt1 11 e "/), lung {/at~ <' 2), thymus (ln11e 3), 
kidney (ln11c 4), and li ver (ln11c 5) as tem plates fo r eD N A synthesis fo llowed 
by PCR am pl ification . Top, PC R. products obta ined using MCP-1 primers: 
1Jotto111 , ;unp lin1ers obta ined w ith {3-actin prin1crs. 
Antibodie s A polyclonal rabbi t an ti-mo use MCP- 1 antibod)' was the 
genero us gift of Dr. 13 arrett R ollins. 13ioti nylated K.I-111 6 {rat an ti-mouse 
1-A") and phycoerythrin-conjugated 30F11 .1 (rat anti-m ouse CD45) were 
pu rchased fro m PharM ingen (San Diego. CA). T he F4/80 (rat anti-mouse 
macrophage) and M1 /70 (rat an ti-mouse CD "l1 b) hybrido ma cell lines were 
purchased from the American Type C ulture Collection (Rockville, MD) 
( 
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Figure 3 . Histology and MCP-1 immunostaining of transgenic skin. Sections of trunk skin from age-matched nontransgenic mice (A) and 
K14/MCP-1 mice (B; M24 line) were stained with hematoxylin and eosin . A~row shows increased numbers of dermal ce lls in K14/MCP-1 mice. Frozen 
sections of age-matched normal (C) and K14/MCP-1 transgenic trunk skin (D, M24) were stained with rabbit anti-mouse MCP-1 and biotinylated goat 
anti- rabbit IgG. 3-amino-9-ethylcarbazo le was used as the substrate and the sections were counterstained with Gill' s hematoxylin. An·ow shows positive 
reaction in basal epidermis of K 14/MCP-1 mice. Scale bars, 10 f.J..m (A,B) and 5 f.J..m (C,D). 
and culture supernatant from these lines was used for immunostaining. 
Supernatant from the N418 hybridoma (hamster anti-mouse CDll c) was 
provided by Dr. Philip King (Memorial Sloan-Kettering Cancer Center. 
New York). 
Keratinocyte Cell Culture Cultures of epidermal keratinocytcs were 
prepared using the ear skin of MCP-1 transgenic mice and nontransgcnic 
controls. Split ca r skin fro m both ears of adult mice was floated dermal side 
down in 6 mg/ml dispase (Grade II , Boehringer Mannheim) in phosphate-
buffered saline for 45 min at 3 7°C. T he epidermis was removed from the 
dermis as a sheet and further digested with 0.3% trypsin (United States 
Biocheinical , C leveland, OH) containing 0.01% DNase I (Sigma, St. Louis, 
MO) for 5 min at 37°C with stirring. The resul ting single-cell suspension 
was filtered through Nitex 88/42 nylon mesh (Tetko, Inc. , Briarcliff Manor, 
NY) to remove clumps and cultured under low-calcium conditions (0.05 
mM Ca ++). Epidermal cell suspensions were plated on collagen-coated 
tissu e-culture d ishes (0.5 mouse equivalents per 60-mm dish) using supple-
mented modified Eagle's medium containing 2.5 ng/ml mouse epidern1al 
growth factor (Collaborative Biomedical Products , Bedford, MA} and 4% 
fetal b ovine serum (Hyclone, Logan, UT} pretreated with C helcx 1 00 resin 
(Bio-Rad Laboratories, Hercules, CA). Conditioned media was collected 
from established keratinocyte cul tures grown for 3 d without m edia 
exchange. 
Chernoattractant Assay Monocyte chemoattractant activity was deter-
mined on human periphera l blood mononuclear cells using a 48-wcll 
micro chamber device as described [24,25]. Supernatants of cultured epider-
mal kcratinocytcs or recombinant murine MCP-1 (gift of Dr. Barre tt 
Rollins) were serially diluted in Gey's balanced sa lt solution containing 
0 .2% bovine serum albumin. Duplicates of each sample were placed in the 
lower wells of a 48 blind-well chemotaxis chamber in a volume of27 f.Ll. A 
5-p.m pore size polyvinylpyrrolidone-free polycarbonatc filter (Nuclcopore 
Corp., Cabin John, MD) was placed in the assembly, and 2 X 105 
mononuclear cells (in 50 f.Ll) were added to the upper well s. After a 90-min 
incubation at 37°C, the fi lters were removed, fixed in absolu te ethanol, and 
stailled with Diff-Q uick stain (Baxter Healthcare Co, McGaw Park, IL}. 
The number of mononuclear cells that migrated through the bottom of the 
filter in each well were counted in five high power fi elds. Polyclonal rabbit 
anti-MCP-1 antibody and nom10l rabbit l gG were used for antibody-
blocking studies. Samples containing transgenic kcrati nocytc supernatants 
or recombinant MCP-1 were incubated with various dilutions of th e rabbit 
anti bodies for 1 h at 4 °C, fo llowed by the addition of protein A- Sepharosc 
beads (Bio-Rad, Hercules , CA) fo r an additional 30 min. The beads were 
then co ll ected by centrifugation and the supernatants used for chemotaxis 
assays as described above. 
Gel E lectrophoresis and Immunoblotting Keratinocyte cul tures 
were prepared as described above and then shifted to m edia w ithout fetal 
bovine se rum. Samples of 3-d keratinocytc supernatants containing 10 f.Lg of 
protein or contro l samples of recombinant MCP-1 were separated by 12.5% 
sodium dodecylsulfate-polyacrylamide gel electrophoresis and transferred 
to a nitrocellulose membrane (BioRad. Hercules, CA) . Blots were blocked 
with 1% gelatin and incubated w ith polyclonal rabbit anti-MCP-1 antibody 
(1 :50 dilution) for 1 h followed by a 1:3000 dilution of alkaline-phos-
phatase-conjugated goat anti-rabbit IgG (Promega, Madison, WI) fo r 30 
min. Western Blue stabilized substrate (Promega) was applied to detect 
membrane bound alkaline phospha tase. 
ELISA for MCP-1 The concentration of MCP-1 in serum and cultured 
keratinocytc supernatants was n1easured by a two-site capture enzynl e-
linked immunosorbent assay (ELISA) with a sensitivity of 0.5 ng/ml [9]. 
The 5 F1 1 capture antibody and the biotinylated 4E2 detector antibody for 
this ELISA were purchased fro m PharMingcn. Binding of th e biotinylated 
antibody was detected by incubation of th e plates w ith avidin-peroxidase 
fo llowed by ABTS substrate (both from Sigma) according to the protocol 
suggested by PharMingen. 
Histologic and Immunoperoxidasc Analyses For routine histology, 
tissue biopsies from anesthetized mice were fixed in I 0% buffered formalin 
and embedded in paraffin. Sections were stained with hematoxylin and 
eosin. For immunohistology, ear o r trunk skin was embedded in OCT 
m edium (Miles, Elkhart, IN) and frozen in cold isopentane. Five micron 
cryostat sections were ftxed with acetone for 1 0 min, fo llowed by staining 
with the primary antibody and the Vcctastain Elite ABC Kit (Vector 
Labo ratories, Burlingam e, CA). Stained slides were developed using 3-ami-
no-9-cthylcarbazo le (AEC} and counterstained with Gi ll 's hematoxylin . 
Contact Hypersensitivity FVB mice and K14/ MCP-·t transgenic mice 
(6-8 weeks of age) were sensitized with 2,4-dinitro-1-fluorobenzene 
(DNFB, Sigma) by hapten application to shaved abdominal wall skin. T he 
sensitizing dose ofDNFB was 50 f.Ll ofDNfB (0.5%, 0.05%, or 0.01 %) in 
4:1 acetone/ o live oil. Five days after sensitization, the n1.ice \Vere challenged 
on each side of one car with 20 f.Ll of0 .2% DNFB in 4:1 acetone/ olive oil. 
Ear thicknesses were measured daily after challenge at three locations on 
each car using engineer's calipers (Dyer Co., Lancaster, PA) and expressed 
as the mean increase in thickness ~ SO above the precha llenge baseline. 
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Adoptive transfer experiments were performed using a modification of a 
previously described method [26]. Briefl y, 50 f.Ll of O.OS'X, or 0.5% DNFB 
was applied to the shaved abdomina l skin of mice and the axillary and 
inguinal lymph nodes were harvested 4 d later. Lymph node cells (4 X 107 
in 200 f.Ll) were transferred intravenously into the ren·o-orbital plexus of 
hapten-naive recipient mice. Immedia tely after transfer, 20 f.Ll of 0.2'% 
DNFB were applied on the right car. T he ear-swelling response was 
measured at 24 h and later as described above. Groups containing 5 to 8 
n1ice were used in a11 contact-h ypersensiti vity cxperizn ents. 
Statistical Analysis T he statisti cal signi fica nce between groups in che-
motaxis assays and contact hypersensitivity experiments was evaluated using 
the Student t test. Data were expressed as mean ::+: SD and were considered 
signi fica nt if p < 0.01. 
RES U LTS 
G e n e ration and Ana ly sis of K14/MCP-1 Transgenic Mice 
T ransgenic mice were generated by pronucl ear inj ecti on of a 
con struc t containing a 2. 1-kb segm ent containing the promoter/ 
enhan cer sequences o f the hum an K 14 gene respon sible fo r ti ssue 
specific ity, as w e ll as a eD N A en coding fo r full-l en g th murine 
M C P-1 (includin g a te rmination codo n) , and intro n/exon contain-
ing sequ en ces from the h GH gene conta ining a polya den ylation site 
(F i g 1). Four fo unders were identifi ed by PC R an alysis o f ta il DN A 
fi·o m 3 7 pups b orn afte r embryo tran sfer. T hree of the four found ers 
were successfully bred to yie lding lines designated M1 4 , M17 , and 
M 24 . South ern bl o t analys is of DNA obta ined fi·om tail skin wi th 
M C P- 1 eDN A, fo llowed by qu antitation by ph ospho r-im ager 
an alysis, indicated that tran sgene copy numbers fo r these lines w ere 
approximate ly 10, 30, and 30, respective ly (no t shown) . Prelimi-
nary expressio n studies in th e two hi gh copy number lines (i. e. , 
M 17 and M 24) revealed similar levels o f ke ratin ocyte M C P-1 
expression both i11 sit11 and ill 11itro. M ost subsequen t experiments 
w ere don e with the M 24 line , alth ough similar phenotypi c fea tures 
were identified upon an alysis of the M17 line. 
To asce rtaiq that the K 14/M C P-1 transgene w as b ein g expressed 
in a tissue-specifi c fashion , RT -PC R w as performed on mRNA 
isolated fro m skin and o the r o rgans , using primers specific for 
mu rine M CP-1, h GH , and {3 actin. T he 421 bp M C P-1 amplimer 
and the 94 bp hGH amplim er w ere only de tec ted in transgenic skin , 
w h ereas the {3-actin amplim er w as de tec ted in both no rmal and 
transgenic skin (Fig 2A). Appro priate ti ssue specificity o f transgene 
expression w as confir m ed by R T-PC R an alysis of mRNA from 
various tissues (Fig 2B). In bo th normal and tran sgenic mice, 
n e ithe r M C P-1 n o r tran sgene mRN A w as de tec ted in ti ssues that 
do not n o rmally contain K 14 expressing cells (e.g. , live r, lung, 
kidney). K 14 is expressed in skin and ton gue , and thymic epith elial 
ce lls also express K 14. 
Biologic and Functional Activity of MCP-1 Protein Pro-
duce d b y K14/MCP-1 Transgenic Keratinocytes M C P-1 
transgeni c mice appeared entirely no rmal, exhibi ting no sign s of 
spontan eous skin di sease. A trivial explana tion fo r th e absence of an 
inflamm ato ry phenotype would be that fun cti onal protein w as no t 
tran slated &·om tran sgenic mRNA in vivo. T w o appro ach es w ere 
taken to es tablish th at M C P-1 prote in w as being produced by 
tran sgenic ke ratinocytes. In th e first, a polyclonal antiserum to 
murin e M C P-1 w as used in an immunohistochemica l analysis o f 
no rmal and tran sgenic m o use skin . Figure 3A,B shows tha t, by 
hem ato,:ylin and eosin staining, no eviden ce of acute inflammato ry 
change between non transgenic (Fig 3A) and transgeni c (Fig 3B) 
skin was o b served . Figure 3D sho w s that epidermis and outer root 
sheath cells from M C P-1 mouse skin sta ined positively with the 
an tibody, w h ereas immuno reactivity was absent in no rmal m o use 
skin (Fig 3C). A second approach in volved culturing murine 
ke ratin ocytes from normal and transgenic mice and assess ing the 
condi tioned m edium fo r immun oreactive M C P-1 by ELISA and 
Western blot. Previ o us studi es ha ve sho wn that murine ke ratino-
cytes cultured in low-Ca + _,_-containing m edium express murine 
K 14 and main ta in ex pression ofK1 4 prom o te r-regulated transgenes 
[23 ). F igure 4A indicates that a Western blot o f m ediu m from 
norm al ke ra tinocytes did no t revea l an immuno reactive species, 
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Figure 4. MCP-1 production by cultured keratinocytes of K14/ 
MCP-1 mice. Immunoblotting analysis for MCP-1 protein {A) was done 
using supernatan ts of cultured ke ratinocytes prepared from the car skin of 
nontransgenic mice (laue 1) and M24 mice (laue 2). Samples of 3-d 
keratinocyte superna tan ts were sepa rated by 12.5% sodi um dodccylsul f.1te-
polyacrylamide gel electrophores is and transferred to a nitrocellulose mem-
brane. T he blot was incubated with polyclonal rabbi t anti-mouse MCP-1 
an tibody, followed by alka line phosphat:lse-conj ugated goat anti-mbbit lgG 
and W estern Blue stabili zed substrate. An MCP-1 specific ELI SA (B) was 
used to quantitate the amount of MCP-1 in supernatants of cul tured 
ke ratinocytes from FVI3, M17, and M24 mice. T he resul ts are presented as 
the mean ::+: SEM. 
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Figure 5. Monocyte chemoattractant activity in dte supernatants of cultured keratinocytes of K14/MCP-l mice and neutralization of 
activity by anti-MCP-1 antibody. A) Supernatams of cultured epidermal keratinocytes fi·om K14 / M C P-1 mice (of'<'ll sq11arcs: M 24 line) o r no n transgenic 
mice (closed rirrlcs) were se riall y diluted in Gey's balanced salt solution. The chem oattractant assay was performed using human mononuclear cell s in a ~ S-well 
microchamber. Migrated ce ll s were counted in duplic;~tc wells and arc reported as mean :!: SD . St<~tistically signiti c;~ nt (p < 0.01) differences arc indicated 
by asterisks. B) Samples comaining M24 kcratinocyte supernatants (opc11 S)'llllwls; 1 :27 dilution) or recombinant MCP-1 (rlasl'd syl!lbols; 100 ng/ ml) were 
incubated with vario us dilutions of anti-MCP-1 o r control rabbit antibodies (triauglcs) fo llowed by removal of <~ntigen-antibody complexes with protein 
A- Sepha rose. l"les idual chemotactic activity of the supernatant was tested o n human m o nonuclear cell s. Results arc expressed as percent inhibition of 
c hen1otaxis relative to controls in which no antibody was added . 
w h e reas ana lys is of 1<.14/MCP-1 medium showed an immunoreac-
tive species that migrated w ith an apparent molecular weight of 
23-29 kD. This molecular weight is in agreement with recent 
immunoblotting data o f murine cells known to express MCP-1 
[27]. By ELISA, kcratinocyte supernatants fi·om both the M 17 and 
the M24 lines conta ined between 8 and 13 ng/ ml of MCP-1 (Fig 
4B). Using the same ELISA method with a sensitivity ofO.S ng/ ml 
[9), we did not detec t MCP-1 in the supernatant of nontransgenic 
keratinocytes cultured under identical conditions. 
Cultured transgenic keratinocyte conditioned medium was tested 
for its capacity to chcmoattra ct monocytes. Human monocytes 
were used for this assay, as they are readil y obtain able and respond 
well to murine MCP-1. Figure SA indica tes that K14/MCP-1 
kera tinocyte medium, but not normal keratinocytc medium, con-
tains a potent monocyte chemoattractant activity that acts on targe t 
cell s in a characteri stic dose-dependent fashion. Figure 5B indi-
ca tes that this chemoattracta nt activity can be completely blocked 
by antibodies to murine MCP-1. 
Augmentation of Contact Hypersensitivity Reactions in 
K14/MCP-1 Mice Because our transgenic mice showed no 
cutaneous inflammation , we considered the possibi li ty that desen-
sitization to MC P-1 had occurred r28] . To test this, we asked 
whether the magnitude of an antigen-driven inflammatory response 
involving T cells and monocytcs was diftc rcnt in 1<14/ MCP-1 
rransgeni cs . Mice were sensitized with varyin g doses of the contact 
sensitizer DNFB on abdomina l skin and cha ll enged epicutaneously 
on the car 5 d later. T here were significant difl:crcnces in the 
response to th is contact sensitizer, and K14/MCP-1 mice showed 
substantia lly greater responses to inte rmediate (O.OS'Yr,) and low 
(0.01%) doses of DNFB (Fig 6A). Furthermore, these en hanced 
responses were longe r lasting in mi ce transgenic for MCP-1. 
Biopsies of challenged car skin confirmed a more pronounced 
inflammatory infiltrate in these mice, with prominent changes at the 
interface between epidermis and dermis most evident in the 
K14/ MCP-1 mice at 72 h (Fig 6B, pane11 versus 2). T his pattern 
of c utaneou s inflammation , known as "lichenoid," is in our study 
associated with a chemokine gradient emanating from epidermis. 
Evidence of persistent interface infiltration could be documented 
fully 7 d after challenge, w h en apparent inflammation h ad ceased in 
controls (Fig 6B, panel 2 versus 4) . 
Enhancement ofBoth Afferent and Efferent CHS Reactions 
in K14/MCP-1 Mice To determine whether changes in the 
afferent phase of CHS were responsible for the above differences, 
both K14/MCP-1 transgenic and non-transgenic littermate mice 
were cha llenged with an intermediate dose ofDNFB (0.05%). Five 
days later, cell suspensions were prepared from lyn1ph nodes 
draining the site of antigen application and were injected intrave-
nously into non-transgenic recipients . Immediately afterwards, the 
recipients were chall enged on the ear with a standard dose of 
DNFB (0 .2%). A highly significant difference was observed, with 
mice that received T cells from K14/MCP-1 transgenic donors 
showing twofold greater CHS responses (Fig 7A) . These data 
indicate that the same dose of antigen, when applied epicutane-
ously, activates antigen-specific T cells more efficiently in K14 / 
MCP-1 mice. The converse experiment was performed as well, by 
transferring lymph-node cells from non-transgeni c mice sensitized 
with DNFB into K14 / MCP-1 or non-transgenic littermate recipi-
ents. Under these conditions, K14/MCP-1 mice showed greater 
car-swelling responses (Fig 7B). The extent to which this enh anced 
efferent response reflects enhanced inflammation versus enhanced 
loca l antigen presentation co uld not be determined fi·om this 
experiment. 
1-A q-Positive Dendritic Cells in the Dermis of K14/MCP-1 
Mice Because th e afFerent limb of CHS seemed to be augmented 
in K14/MCP-1 mice, we asked whether a diffe rence in the number 
of antigen-presenting cells could be seen in transgenic mice. 
Immunohistochemical ana lysis was performed using antibodies to 
1-A '1, the class II major histocompatibility complex molecule ex-
pressed by FVB/N mi ce. Although numbers ofLangerhans cells in 
the epidermis were similar (not shown), a dramatic increase in the 
nll!nber of 1-A ''-positive cells was readil y observed in dermis (Fig 
8, panels 1 versus 3). Many of these cells had an obviously dendritic 
morphology (panel 4), and were often clustered near the dermal 
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Figure 6 . Exaggerated CHS reactions in K14/MCP-1 mice after 
suboptimal sensitization with DNFB . A) Nontransgenic mice (closed 
circles) and K 14/MCP-1 mice (ope11 sq 11nres, M24 line) were sensitized with 
dillercnt con centrations ofDNFB (O.S'X>, 0.05%, 0.01 %). Five d<tys later, the 
ri gh t cars of the sens itized mice were challenged with ONFB (0.2%) and ca r 
swel1ing was n1casured. All car-swelling 111Casuren1cnts arc reported as 111 ca n 
:t SD. The groups of K14/MCP-1 mice (M24 Line) sensitized with the 
lower doses of ONFB (0.05%, 0.01%) showed significant differences in ca r 
swelling at 24 and 48 h compared to normal mice (*p < 0.01 ). B) Ear skin 
from nontransgenic (1 and 3) and transgenic (2 and 4) mice sensiti zed with 
0.5% ONFB and cha ll enged 5 d later w ith 0.2% ONFB was biopsied 72 h 
after challenge (1 and 2) or 7 d after challenge (3 and 4) and st<t ined with 
hematoxylin and eosin. Scale bnrs, 5 JLm. 
epidermal junction and around hair folJicles; that is , in apposition to 
epith elial cells producing transgenic M CP-l i11 si/11. Using two-
colo r flu orescen ce-activated cell sorter analysis, all of the I-A q ce ll s 
in cell suspensions derived from both epidermis and dermis were 
judged to be bone marrow- derived by virtue of their expression of 
the comm o n leukocyte antigen CD45 (data not shown). 
Dendritic cells are considered by some to represent a lineage 
independent from monocytes and macrophages [29], and have been 
shown to be the most efficient cells at presentation of nominal 
antigen to naive T cells [30]. Several antibodies that selectively bind 
to m o use dendritic cells have been described, and we asked 
whether the pattern of staining using these antibodies differed in 
norm al and transgenic mice. N418, which reacts with CD11c, has 
been considered to be relatively specific for murine dendritic cells 
and does not react with peritonealmacrophages [31]. N41 8 stained 
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Figure 7. Enhancement of the afferent and efferent phases of the 
CHS response in K14/MCP-1 mice. A) To compare the degree of 
sens iti zation occurrin g in the afferent phase of the CHS respo nse, nontrans-
gcni c mice and K14/MCP-·I mice (M24 line) were sensitized w ith ONFB 
(0 .05%) and draining lymph n odes ha rvested 5 d late r. T he ce ll suspens io n s 
were tra nsferred in travei1o usly into hapten-naive nontransgcni c FVB nllce. 
These mice were immediate ly challenged w ith ONFB (0.2%) after transfer. 
Ear-swelling measurements are reported as mean ::':: SO . Recipients of 
immune cells from K14/MCP-1. mice (open squares) showed enhanced CHS 
responses at 24 and 48 h compared to recipients of immune ce lls from FVB 
mice (closed circles) ('' p < 0.01) . B) To compare the strength of the efferent 
response , ONFB (0.5%) was app li ed to no rmal mice and draining lymph 
nodes were harvested 5 d la ter. T he cel l suspensio n (in 200 JLI) was 
transferred intrave no usly in to hapten-nai ve 1<.14/MCP-1 mice o r nontrans-
geni c mice. Immediate ly afte r tra nsfer, ONFB (0.2%) was applied to the 
right car. Ea r-swelling m eas urements arc reported as mean :t SO. Ope11 
squares show K14/MCP-1 rec ipient mice (M24 line) and closed circles show 
no n transgenic recipients (*p < 0.01 ). 
a subset of dendritic cells in normal mouse dermis and epidennis, 
and the number of N418- positive cells in K14/MCP-1 skin was 
clearly increased (not shown) . Other subsets were positive for 
markers not specifi c for either dendritic cells or monocytes, such as 
F4/80 and CDllb (not shown). 
T he presence of both N418 and F4/80 on dendritic cells in the 
dermis of the K14/MCP-1 mice suggested that at least some of 
these cell s might b e Langerhans ce iJ s o r their precursors, perhaps en 
ro ute to (or from) the epidermis . Langerhans cells in epidermis are 
ch aracterized by distinctive o rgan ell es known as Birbeck granules 
[32,33). Electron microscopic analysis of K14/MCP-1 dermis re-
vealed dendritic cell s with readily discernible Birbeck granules in 
their cytoplasm (not shown) . No Birbeck granules could be iden-
tified in non-tran sgenic mouse dennis in agreement with the results 
of others [34,3 5], whereas Birbeck granules were evident in both 
transgenic and non- transgenic epidermal Langerhans cells, as ex-
pected (not show n) . T he accumulation of Langerhans cells (or 
re la ted ce ll s) in K14 / M CP-1 dermis without a concomitant in-
crease in the number of epidermal Langerhans cells may reflect the 
fact that, under normal conditions, available sites for Langerhans 
cells in epidermi s are nearly saturated. 
DISCUSSION 
We have created three independent lines of transgenic mice that 
express high and readil y detectable levels of the ch emokine MCP-1 
in basa l keratinocytes of stratified squamous epithelial tissue, par-
ticularly epidermis. M CP-1 is best understood as a chemotactic and 
activating factor for monocytes [7 ,36], basophils [2], and T cells 
[12], yet no spontaneous infiltration of these cell s into skin could be 
identif~ed in spi te of production i11 situ by basal keratinocytes. How 
can these observations be reconciled? Primary cytokines, including 
the tumor necrosis factors and inte rle ukin 1 s, were defined as 
molecules that were n ecessary and sufl'icient for the induction of 
local inflammatory responses [37,38] . For example, interleukin-1 
can induce endothelial selectin expression, chemokine production, 
and endotheli al intercellular adhesio n molecule-1 and vascular cell 
adhesion mol ecule-1 expression, and when injected subcutaneously 
causes brisk inflammation [39]. According to this primary cytokine 
paradigm, MCP-1 alone sho uld be inefficient at indu cing a local 
inflammatory response, in that endothelial activation is not in the 
repertoire of its effects. Direct injection of MCP-1 into skin has 
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yielded conAicting results, in som e studies inducing m on ocyte 
infil tration [40] an d in others havin g li t tl e e ffect [5]. O ur data 
suggest that M C P-1 alon e is insuffic ie nt to induce a class ical 
inflammatory response. 
One poten tial explanation for the lack of spontaneous inAamma-
tion is th at, in o ur transgenic mice, responsive subsets ofl eukocytes 
have becom e desensitized to M C P-1 thro ugh repetitive stimula-
tion . Precedence fo r such a phen om enon occurring in transgenic 
mjce was o bserved in a recent report describing overproductio n of 
IL- 8 i11 vivo [28]. In this study, neu trophils los t their capacity to 
ext ravasa te in the face of an inAammatory challenge . Several lines 
of evidence argue agrunst this possibiljty. First, enhanced C H S 
resp onses wo uld not be expected if T cells capable of responding 
chem otactica lly to MC P-1 [9, 12] w ere paralyzed with respect to 
their abil ity to fo llow chem okjne g radients. Second, we w ere 
unable to de tect e levated serum levels of MC P-1 in o ur transgenic 
mice using an ELI SA sensitive to le vels as low as 0.5 ng/ml (data 
not shown) . T hus, most circulating m onocytes and T cells do not 
appear to be exposed to high levels of M CP-1 i11 JJ iJIO in these mice. 
Third , there is eviden ce th at cell s that do resp ond to M C P-1 
(dendriti c cells, Langerhans cells) have migrated i11 11 i 11o to sites 
where the levels o f M C P-1 sho uld be marim al. Although the 
studies outlined above do not address the issue of how w ell th ese 
p u tative antigen-presenting cells function on a per cell basis, it is 
not able th at low doses of contact sensitizer e licited a stronger 
reac tion in the M C P-1 transgenic mice, in dicating th at such 
prop erties were at the very leas t not diminished . 
Because M C P-1 pro duced by cultured transgenic keratinocytes 
was chem otactic for T cells and m on ocytes i11 vit ro , w hy is it th at 
only dendritic cells and Langerhans cells were shown to increase in 
number in skj n i11 vi vo? A trivial possib ili ty is that these latter cells 
are m ore sensi tive to M C P-1 and may respond to it at levels that are 
invisible to other leukocytes. H owever , Langerhans cells and 
dem1al dendritic cells exit vesse ls in skjn under no rmal physio logic 
con d itions in the apparent absen ce of inAammation [41-43] . T his 
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F igure 8. Immu n ohis to c h e m ical 
s taining o f d ermal d endri t ic ceJls 
in K1 4/MCP-1 tnic e a nd non tran s -
gcnic tnicc . Frozen sections of trunk 
skin frotn agc-n1atchcd nontransgcnic 
m ice (A 1. A2) and M24 mice (A3. A4) 
were sta ined w ith antibodies to M H 
class II (I-A"). 3-amino-9-ethylcarba-
zo le was used as a substrate and the 
slides we re countersta.incd with Gill" s 
hematoxylin . Scale hnrs, I 0 p..m in A I . 
A3, and 2 .5 p..m in A2, A4. 
physio logic emig ration of dend ri tic le ukocytes fi·om vesse ls may 
occur thro ugh a pathw ay distinct fro m the mul tistep path way of 
acute inA ammation th at in volves sequen tia l in teractions w ith selec-
tins, ch em okj nes, and immunoglob ulin superfa mil y cell ad hesio n 
m o lecu les [38]. We propose that this physiologic emigration of 
dendritic leukocytes fro m blood vesse ls in deni1 is is exaggerated in 
transgenic mice, e ither beca use dend1·itic cell s responsive to MCP- 1 
exit vesse ls more efficiently o r because they accumulate in the face 
of a persistent gradien t of M C P- 1 em anating from th e epi derm is. In 
support of this explanation is the observation th at on ce an acute 
leukocytic infiltra te is recrui ted to skin (i. e., dm·ing con tact h yper-
sensitivi ty) , the pattern of in fi ltration changes. Altho ugh in no n-
transgenic mice th e infiltrate is presen t thro ugho ut th e dermis, in 
K 14/M C P-1 transgenjc mice the m o n onu clear leukocytes arc m ost 
abundant at the de rm al epiderm al j un ction (Fig SB). T hjs en-
croachm en t of the de rmal-epidermal j un ction by a cellular in fi ltrate 
has been described as " lich en oid ," and several derm a to logic d is-
cases arc characterized by such a pattern [33]. O ur resul ts in dicate 
th at a chcm okine gradien t emanatin g from basa l epiderm is can 
reproduce a lichen o id in fi ltrate, and suggest a mech anism fo r 
certa in histopath o logic fea tures of such diseases . 
Dendri tic cells are a fa mily of bon e m arrow-derived cells with a 
distinctive m orphology that share the capacity to presen t an tigen 
effi c iently to T cells [29]. M any epi the lia l tissues lining inte r faces 
w ith the en viro nment contain de ndri tic cells, and Langerhan s cells 
in epidermis and o ral mucosa are the best studied examples . 
Dendri tic cells that appear to be di sti nct from Langcrh ans cells also 
res ide in dermis [34], and can be fo und in blood and lym ph oid 
o rgan s as well [34,44,45]. W hether these la tter cells rep resent 
Langcrhans cells that have been activated by cytokjn es such as 
granulocyte macrophage colon y- stimulating facto r [46] , or w hether 
th ey represent d istinc t sub types of dendritic ce lls, has not yet been 
established . Alth o ugh it is clear that den dri tic cells that res ide in 
peripheral tissues m ay carry an tigen via d raining lym phatics to 
peripheral lymph no des to ma ximize the efficien cy of an tigen 
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presentation toT cell s 143,47], the mechanism by which such cells 
ex it th e circulation to migrate to peripheral ti ssue ha s not been 
exp lored. O ur data indicate that chcmokines such as M C P-1 can 
inHu ence thi s process. 
T he re is evidence that overcx press ion of M C P-1 in hum an skin 
disease is associated w ith an inc rease in derma lmonocytes. A recent 
report indicated that in les ions of psoriasis, basal keratinocytes make 
in creased amo unts of M CP-1, a findin g associated with increased 
numbers of m onocytes and macro phages ncar the derma l-ep ider-
mal junction 148]. Another repo rt suggests that low but detectable 
levels of MCP-1 ca n be observed in norma l uninflamed hum an 
epidermi s [49] . Although we did not o bserve MCP-'1 in non-
transgeni c m o use skin, it may be that o ur m ethodo logy w as 
insuftic ientl y sensitive to detect such low leve ls. If the o bservation 
of M CP-·t in normal epide rmis can be conl'irm ed , thi s ma y provide 
a physiologic m echani sm whereby La ngerhan s ce ll s m ay be at-
tracted to and loca lize w ithin the epiderm is. Although it is true that 
M C P-1 transgen ic ep ide rmis d id no t contain substa ntially m o re 
Langcrhans cell s than no rm al epide rmis, sites for Langerhans cells 
in epidermis arc like ly to be nearly saturated unde r no rmal condi-
tio n s, and ce lls de stined for epidermis m ay accum ul ate in de rmi s. 
Altho ugh the enhanced C HS responses we o bserved in the 
K 14/MCP- 1 transgeni c mi ce argue strong ly aga in st this chem oki ne 
ca using globa l desensitization of target ce lls, m ore than one mech-
anism may be responsibl e for this enhanced response. Standard 
sensitization doses of contact sensitizer lead to a m odest bu t 
reproducibl e enhan ce m ent of a C H S response on challenge. Large 
differences in the magnitude of the C I-I S response in K1 4/M C P-1 
tra nsgenic mice was best observed when the sensitizing dose was 
lowered to O.OS'Y,, , and at the lowest dose of DNFB (0.01%), an 
antigen-specific respo nse w as dem onstrable on ly in the 1<.'14/ 
M C P-1 transgenic mice. At least two no n-mutually exclusive 
possibil ities ex ist for these d ata . First, it m ay be that in creased 
numbers o f dendriti c antigen-presenting ce ll s in K1 4/M C P-'I trans-
genic mice c'nhance the sensiti vity o f the immun e system to DNFB 
by increasin g the like lih ood that it will be produ ctive ly presented to 
the T cell. Alte rnative ly, it is poss ibl e that antigen non-specific 
inflammation mi ght be e licited in the MCP- ·t transgcnics, thus 
in creas ing the in tensity of the response by more efficiently recruit-
ing T cells and antigen-recepto r negative leukocytes to chall enged 
skin . The cell-transfer experim ents suggest that both m echanism s 
arc at play. 
O ur data suggest a prev iou sly unappreciated ro le of chemokincs: 
tha t of influencing the ph ys io logic recruitment of bone marrow-
derived epithe lial symbio nts to the ir pe ripheral sites of res iden ce. 
Whether M C P- 1 or a re lated chcmokine is in f.1ct the authentic 
phys io logic Langerhans o r dendritic ce ll chemotac ti c factor remains 
to be determined . H oweve r, it suggests that leukocytes that 
no rmall y ex it vesse ls to traftic in peripheral tissues can be pro-
fou ndly influ enced by chcmokin c g radiem s emanating from tissues. 
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ALFRED-MARCHIONINI-PRIZE 1997 
T he X IX . CO N G R.ESSUS MUNDI D ERM ATOLOG IAE. w hi ch is to be held in 1997 in 
Sydney, has been chosen as the venu e fo r th e ALFR..ED- M ARCHI O NI N I- PRI ZE awa rd 
cerem ony. T he prize consists of two parts, th e ALFR..ED-M Ail...CHI O NI N I-M EDAL in gold 
and the AL FR .. ED-MAR C I-II O NINI-R.ESEAR.C l-1-PR.I ZE. N omina tions fo r the ALFR.ED-
MA R.C H IO N IN I-RESEA R.C l-1 - PR.I ZE shou ld be submitted to the C hairm an of the .Board of 
T ru stees of th e ' ' ALFR..ED-M AR C HI O N INI - PR.I ZE" Foundati on by June 30th. 1996 at the 
latest at the to ll o wing addresses : Pro fessor 1-1 . 1-1 . W o lff", M .D .. Director of the U niversity. 
Dermatologica l C lini c Llibeck , Ratzeburger All ee 160, D-23538 Lcibeck , Germany o r T he 
Director of the ALFR..E D-M AR C HI O N INI- FOUNDATION fo r the Furth erance of Med ical 
Science, Dan ziger Straf3e 5. D-2 1465 Reinbek, Germany. 
N om ina tio ns fo r th e ALFR.ED- M Ail...C HI O NINI-R..ESEA R.C l-1 - PRI ZE m ay be made by the 
Fo undati on itself, members of the Board of T ru stees and the heads of clinics . resea rch 
estab li shments, and other sc ientific institutes and socie ties. 
Eligible fo r th e ALFRED-MArl...C HI ON INI-R.ESEAR C I-1 - PR.lZE arc deserving youn g 
scientists (uni versity lec turers, seni o r phys icians, scientific ass ista nts) ft·01n the medica l fac ul ty 
(in cludin g veterinary and den tal science) as well as fro m the fi elds of bi ochemi sn·y and 
bio pharma cy. Candida tes of all nati onali ties will be e lig ible . 
T he prize w ill be awarded fo r personal characteri stics as we ll as dedication to inte rn ational 
communicatio n as pro moted by Alfred Marchi onini and the candida te 's sc ien tifi c contribu tio n 
to da te , which must be o f particular importa nce fo r in te rnatio nal de rm atology. 
N o mina ti ons sho uld in clud e a comprehensive apprecia tion o f the candid ate, g iving va lid 
reasons fo r his / her suitabi li ty as an award-winner, and all the doc um en tation necessa ry fo r 
pro per consid eration of the candidate by the Board o f T ru stees . 
Th e ALFil...ED-M AR C I-II O N INI-R..ESEA R.C l-1-Pll...I ZE 1997 is endow ed with 20,000 . 
Deutschm arks. 
